Results 141 to 150 of about 25,871 (216)

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis. [PDF]

Brain
Maleska Maceski A, Benkert P, Einsiedler M, Schaedelin S, Oechtering J, Melie-Garcia L, Cagol A, Galbusera R, Galli E, Müller J, Finkener S, Lalive PH, Uginet M, Müller S, Pot C, Mathias A, Du Pasquier R, Hoepner R, Chan A, Disanto G, Zecca C, D'Souza M, Hemkens LG, Yaldizli Ö, Derfuss T, Roth P, Gobbi C, Brassat D, Tackenberg B, Pedotti R, Raposo C, Oksenberg J, Green AJ, Wiendl H, Berger K, Hermesdorf M, Piehl F, Conen D, Kappos L, Khalil M, Granziera C, Abdelhak A, Leppert D, Willemse EAJ, Kuhle J, Swiss Multiple Sclerosis Cohort (SMSC) .   +45 more
europepmc   +1 more source

Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications. [PDF]

Neurol Neuroimmunol Neuroinflamm
Mariotto S, Cobo-Calvo A, Khalil M, Armangue T, Aktas O, Höftberger R, Neuteboom RF, Pröbstel AK, Reindl M, Waters PJ, Arrambide G, Paul F, Palace J, Marignier R, Hacohen Y, as the MEDEN (MOGAD Eugène Devic European Network) Steering Committee.   +15 more
europepmc   +1 more source

Glial cells: managers of Neuro-immunityEditorial

Frontiers in Cellular Neuroscience, 2016
Carlos eBarcia, Gilles J. Guillemin, James Francis Curtin, Jeffrey Michael Zirger   +3 more
doaj   +1 more source

Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial. [PDF]

Nat Cancer
Bunse L, Lindner K, Wick A, Freitag A, Lanz LM, Edelmann D, Suwala A, Breckwoldt MO, Harting I, Sahm F, Schlenk RF, Schmitt A, Schnell O, Hense J, Misch M, Krex D, Denk M, Walz J, Steinbach JP, von Deimling A, Schmitt M, Bunse T, Tabatabai G, Bendszus M, Poschke I, Wick W, Platten M.   +26 more
europepmc   +1 more source

Editorial: Reviews in: multiple sclerosis and neuroimmunology. [PDF]

Front Neurol
Mirmosayyeb O.
europepmc   +1 more source

Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study. [PDF]

Ther Adv Neurol Disord
Chico-Garcia JL, Morales de la Prida M, Boix Lago A, García-Domínguez JM, Sepúlveda M, Martínez-Hernández E, Guasp M, Fonseca E, Calvi A, Alba-Isasi MT, Albertí B, Cid J, Lozano M, Charry P, Rodríguez-Jorge F, Sainz-Amo R, Sainz de la Maza S, Monreal E, Villar LM, Masjuan J, Valero-López G, Millán-Pascual J, Cuello JP, Palacios M, Gifreu Fraixinó A, Martínez-Gins ML, Álvarez Bravo G, Meca-Lallana JE, Costa-Frossard L, Blanco Y, Cabrera-Maqueda JM, Saiz A, Llufriu S.   +32 more
europepmc   +1 more source

A systematic approach to identify gaps in neuroimmunology: TNF-α and fear learning deficits, a worked example

Background: The pathophysiology of several neurodegenerative and neuropsychiatric disorders is linked to an altered immune system. However, it is often unclear how the immune system specifically affects these disorders since neuroimmune interactions are ...
Afd Pharmacology, Hessel, Ellen V.S., Groenink, Lucianne, Risseeuw, Tristan A., Heesbeen, Elise J., Pharmacology, Bijlsma, Elisabeth Y.   +6 more
core  

Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis. [PDF]

Front Neurol
Annovazzi P, Clerico M, Cocco E, Conte A, Marfia GA, Salvetti M, Tomassini V, Totaro R, Centonze D.   +8 more
europepmc   +1 more source

Myelin Oligodendrocyte Glycoprotein Antibodies in Breast Milk in a Lactating Woman With Severe Enterovirus-Associated MOGAD. [PDF]

Neurol Neuroimmunol Neuroinflamm
Kammermeier S, Heck S, Zimmermann H, Engels D, Reindl M, Kümpfel T.   +5 more
europepmc   +1 more source

Recent Advances in Pediatric-Onset Multiple Sclerosis: From Early Diagnosis to Precision Care. [PDF]

Children (Basel)
Lechner C, Breu M.
europepmc   +1 more source